| Serial Number | 79392510 |
| Word Mark | RHEUMATRACE |
| Filing Date | Tuesday, September 19, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Monday, January 13, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes, namely, diagnostic testing services; testing services relating to the detection and measurement of biomarkers, namely, biomarker testing for medical research purposes; testing samples for the presence of biomarkers, namely, biomarker testing for medical research purposes; medical research laboratory services; medical research laboratory services; research laboratory services in the field of medicine; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services, namely, biological testing for medical research purposes; advice, information and assistance relating to the foregoing |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 1, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nordic Bioscience A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Event Date | Event Description |
| Thursday, March 28, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, April 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 5, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, May 13, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 31, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, June 14, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, June 27, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, June 27, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, July 15, 2024 | REFUSAL PROCESSED BY IB |
| Thursday, December 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 13, 2025 | FINAL REFUSAL E-MAILED |
| Monday, January 13, 2025 | FINAL REFUSAL WRITTEN |
| Monday, January 13, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, January 20, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 20, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 20, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |